RA
MACK

Rosalind Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Rosalind Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60,000
Closed -$805K – 41
2023
Q4 		$805K Buy
+60,000
New +$805K 0.66% 24